CClinicalTrials.gg
CompletedNCT00673946Updated Dec 9, 2013

Impact of Oximetry on Hospitalization in Acute Bronchiolitis

A Phase 4 interventional study of True saturation values displayed and Altered saturation values displayed. in Bronchiolitis, sponsored by The Hospital for Sick Children. Completed at 1 site in Canada. Open to participants aged 6 Weeks to 12 Months. Per ClinicalTrials.gov, last updated 2013-12-09.

Sponsored by The Hospital for Sick Children · Phase 4, Interventional, and Diagnostic

Phase
Phase 4
Study type
Interventional
Enrollment
213
Allocation
Randomized
Ages
6 Weeks to 12 Months
Sex
All
01

Study summary

To determine, in previously healthy infants 6 weeks to 12 months of age, diagnosed with acute bronchiolitis and monitored by hourly oximetry, if the probability of hospitalization within 72 hours of arrival in those whose oxygen saturation display is manipulated 3 percentage points above the true measurements is significantly lower in comparison to those whose monitors display true saturations.

Read the detailed description

This is the first bronchiolitis study to examine the clinical and economic impact of making disposition decision on primarily clinical grounds, while blinding the physicians to oxygen saturations by providing them with either true saturation measurements or those which are 3 percentage points above the true values. Although physiologically insignificant and within the measurement error of the instrument, this difference has been shown to be perceived as clinically relevant and to have a major hypothetical impact on disposition, without any evidence to support this belief.

We hope to find out if children with oxygen saturations above or in the vicinity of the threshold recommended for initiation of oxygen therapy by the AAP can be safely discharged based on their clinical appearance rather than to have their hospitalization dictated by a locally defined number. This study will hopefully provide much needed evidence necessary to help us interpret the oximetry results more meaningful which may in turn lead to fewer hospitalizations, shorter length of hospital stay and lower health care costs.

02

Conditions studied

  • Bronchiolitis

Browse trials for

Keywords

  • bronchiolitis
  • hospitalization
  • oximetry
  • pediatrics
03

In context

Bronchiolitis

360 studies on the registry are indexed under Bronchiolitis; 43 are open to participants now.

This study's enrollment of 213 is above the median of 80 across 249 interventional studies indexed under Bronchiolitis.

Browse Bronchiolitis studies →

Lead sponsor

The Hospital for Sick Children is the lead sponsor of 568 studies on the registry; 81 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Weeks to 12 Months
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Acute bronchiolitis
  • Age 4 weeks to 12 months
  • Baseline Respiratory Disease Assessment Instrument (RDAI) ≥ 3 points
  • Informed consent
  • Availability of a telephone

Exclusion criteria

Exclusion Criteria:

  • Pre-existing pulmonary or cardiac distress, neuromuscular disease, congenital or acquired airway anomalies, hemoglobinopathies, or chronic hypoxia
  • Severe respiratory distress, defined as the retraction component on the RDAI as 8 out of possible 9 points
  • True baseline oxygen saturation less than 88% in room air
  • Transfers from other institutions
05

Study design

Phase
Phase 4
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
213 participants (actual)

Study arms

  • Active comparator
    1

    In this arm, patients are monitored with oximeters displaying true saturation values

    Other: True saturation values displayed

  • Experimental
    2

    In this arm, patients are monitored with oximeters with displayed saturations 3 percentage points above true values

    Other: Altered saturation values displayed.

Interventions

  • OtherTrue saturation values displayed

    Physicians will be presented with real saturations.

  • OtherAltered saturation values displayed.

    Physicians will be presented with saturation measurements three percentage points above the true values.

06

What researchers measure

Primary outcomes

  1. Hospitalization for bronchiolitis

    Time frame: 72 hours from start of study

Secondary outcomes

  1. The proportions of infants receiving supplemental oxygen in the ED

    Time frame: 72 hours from start the study

  2. Length of stay in the ED (from the time of arrival to the disposition decision)

    Time frame: Determined by outcome measure

  3. Proportions of infants with unscheduled medical visits for bronchiolitis symptoms to any medical facility

    Time frame: 72 hours from start of study.

  4. Proportion of the ED staff/fellows in "strong agreement" or "agreement" with discharge

    Time frame: 0, 60, 120, 180, 240, 300, and 360 minutes

07

Study locations

1 site
  • The Hospital for Sick Children
    Toronto, Ontario, Canada
08

References and documents

Publications

  • Schuh S, Freedman S, Coates A, Allen U, Parkin PC, Stephens D, Ungar W, DaSilva Z, Willan AR. Effect of oximetry on hospitalization in bronchiolitis: a randomized clinical trial. JAMA. 2014 Aug 20;312(7):712-8. doi: 10.1001/jama.2014.8637. PubMed 25138332 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 9, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00673946
Lead sponsor
The Hospital for Sick Children
Responsible party
Suzanne Schuh (Staff Physician, The Hospital for Sick Children) — Principal investigator
First posted
May 7, 2008
Start date
Mar 2008
Primary completion
May 2013
Completion
May 2013
Last update
Dec 9, 2013

Study contacts

Suzanne Schuh, MD
principal investigator · The Hospital for Sick Children

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion